Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,521 | 248,600 | 138,218 | 91,764 | 193,018 |
| Marketable Securities | 755,509 | 741,318 | 392,990 | 451,180 | 372,670 |
| TOTAL | $905,651 | $998,658 | $540,141 | $553,550 | $578,017 |
| Non-Current Assets | |||||
| PPE Net | 27,467 | 28,323 | 29,314 | 29,736 | 28,449 |
| Investments And Advances | 58,126 | 39,863 | 0 | 7,928 | 52,269 |
| Other Non-Current Assets | 26,578 | 26,868 | 27,202 | 27,338 | 30,184 |
| TOTAL | $112,171 | $95,054 | $56,516 | $65,002 | $110,902 |
| Total Assets | $1,017,822 | $1,093,712 | $596,657 | $618,552 | $688,919 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,061 | 14,971 | 11,008 | 8,183 | 11,298 |
| Accrued Expenses | 59,604 | 42,264 | 43,063 | 24,572 | 28,803 |
| TOTAL | $72,564 | $60,020 | $56,743 | $35,318 | $42,538 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 424,020 | 430,330 | 87,100 | 61,735 | 67,652 |
| TOTAL | $424,020 | $430,330 | $87,100 | $61,735 | $67,652 |
| Total Liabilities | $496,584 | $490,350 | $143,843 | $97,053 | $110,190 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,657 | 156,323 | 148,502 | 148,289 | 148,007 |
| Common Shares | 16 | 16 | 15 | 15 | 15 |
| Retained earnings | -967,755 | -874,947 | -775,009 | -684,538 | -616,244 |
| Other shareholders' equity | 3,097 | 5,194 | 7,988 | -1,334 | -986 |
| TOTAL | $521,238 | $603,362 | $452,814 | $521,499 | $578,729 |
| Total Liabilities And Equity | $1,017,822 | $1,093,712 | $596,657 | $618,552 | $688,919 |